AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
arXiv:2401.02149 · doi:10.1039/D3NR04777F
Abstract
Comparison of click chemistry and sortagging grafting strategies for functionalizing AGuIX nanoparticles with nanobodies to develop a tri-functional technology combining MRI imaging, radiotherapy, and immunotherapy by inhibiting immune checkpoints.
Nanoscale, 2024